Suzhou Highfine Biotech Co., Ltd. (SHE:301393)
China · Delayed Price · Currency is CNY 52.65
-0.35 (-0.66%)
At close: Feb 13, 2026
Suzhou Highfine Biotech Revenue
Suzhou Highfine Biotech had revenue of 164.40M CNY in the quarter ending September 30, 2025, with 59.45% growth. This brings the company's revenue in the last twelve months to 558.41M, up 35.11% year-over-year. In the year 2024, Suzhou Highfine Biotech had annual revenue of 451.87M with 16.22% growth.
Revenue (ttm)
558.41M
Revenue Growth
+35.11%
P/S Ratio
10.09
Revenue / Employee
1.30M
Employees
428
Market Cap
5.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 451.87M | 63.08M | 16.22% |
| Dec 31, 2023 | 388.79M | -58.66M | -13.11% |
| Jan 1, 2023 | 447.46M | 78.02M | 21.12% |
| Dec 31, 2021 | 369.44M | 87.09M | 30.85% |
| Dec 31, 2020 | 282.35M | 91.10M | 47.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition